Reveal LINQ vs uCT 780

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Reveal LINQ

by Medtronic

uCT 780

by United Imaging Healthcare

AI Verdict

These tools are adjacent rather than direct competitors, both serving cardiology but with distinct functions. The Medtronic Reveal LINQ is an implantable cardiac monitor utilizing AI for continuous, long-term ECG rhythm detection, whereas the United Imaging uCT 780 is a CT scanner that employs AI for enhanced image acquisition and workflow in anatomical and cardiac imaging. A clinician would typically choose between them based on the need for either prolonged arrhythmia detection or detailed structural visualization.

Choose Reveal LINQ if…

Choose Reveal LINQ if you require long-term, continuous monitoring for intermittent or suspected cardiac arrhythmias that are difficult to capture with traditional methods. This implantable cardiac monitor is ideal for patients experiencing unexplained syncope, cryptogenic stroke, or suspected atrial fibrillation who need prolonged, discreet monitoring for up to three years.

View Reveal LINQ →

Choose uCT 780 if…

Choose uCT 780 if you need high-resolution, detailed anatomical imaging, particularly for advanced cardiac diagnostics and complex vascular assessments. This 160-slice CT scanner is best suited for scenarios demanding rapid image acquisition, low radiation dose, and superior image quality, even in the presence of metal implants.

View uCT 780 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Reveal LINQ	uCT 780
Deployment	The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.	On-premise
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Reveal LINQ

Tool A (Reveal LINQ) offers high usability through its minimally invasive implant procedure and remote monitoring capabilities via a bedside unit and mobile app, simplifying long-term patient management. Tool B (uCT 780) is a large, on-premise imaging system that requires trained operators, making its usability more about workflow efficiency for technicians rather than direct patient or remote clinician interaction.

Clinical Value

Reveal LINQ

Tool A (Reveal LINQ) provides continuous, long-term ECG monitoring for up to three years, with AccuRhythm AI algorithms specifically designed to reduce false alerts for cardiac arrhythmias, directly improving diagnostic efficiency and reducing clinician burden. While Tool B (uCT 780) offers high-quality, low-dose anatomical imaging with advanced hardware and AI-powered workflows, Tool A's direct AI impact on diagnostic accuracy by reducing false positives offers a distinct and quantifiable clinical benefit for long-term patient management.

Pricing & Value

Tie

Both tools are high-value medical devices with pricing that is not publicly disclosed and requires direct consultation with the respective vendors. Without specific pricing information or comparative cost-effectiveness studies, it is impossible to determine a winner in this dimension.

Enterprise Readiness

Tie

Both Medtronic (Tool A) and United Imaging Healthcare (Tool B) are established medical device companies with FDA clearance and HIPAA compliance, indicating their products are designed for secure and compliant integration into healthcare enterprises. While their deployment models differ (implantable with remote network vs. on-premise scanner), both demonstrate the necessary certifications and company infrastructure for enterprise adoption.

Innovation

Reveal LINQ

Tool A (Reveal LINQ) stands out for its innovation as the 'world's smallest insertable cardiac monitor' and its AccuRhythm AI algorithms that specifically reduce false alerts for AF and pauses, directly addressing a key challenge in long-term cardiac monitoring. While Tool B (uCT 780) features significant innovations in CT imaging hardware and AI-empowered workflows for image quality and dose reduction, Tool A's miniaturization and targeted AI for diagnostic accuracy represent a more distinct and impactful innovation in its specific clinical niche.

Support & Docs

Tie

Both Medtronic and United Imaging Healthcare are major global medical device manufacturers, implying robust support, training, and documentation for their complex products. Medtronic provides extensive patient and professional resources for Reveal LINQ, including technical services and patient services. Similarly, United Imaging Healthcare, as a global company, offers comprehensive service and support for its imaging systems. Without specific comparative metrics on the quality or breadth of their support and documentation, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Reveal LINQ	uCT 780
Name	Reveal LINQ	uCT 780
Company	Medtronic	Shanghai United Imaging Healthcare Co.
Description	Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.	The uCT 780 is a 160-slice CT scanner from United Imaging Healthcare, integrating AI-powered workflows and advanced hardware for high-quality, low-dose imaging, particularly for cardiac and detailed anatomical scans. It is not an AI tool for a physician directory, but a medical imaging device.
Tagline	The world's smallest insertable cardiac monitor with AI-powered accuracy.	Intelligent CT Imaging for Precision Diagnostics
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Radiology & Imaging AI
Specialties	Cardiology, Neurology	Cardiology, Interventional Radiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Reveal LINQ and uCT 780.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications for the Medtronic Reveal LINQ and the United Imaging uCT 780?

The Medtronic Reveal LINQ is a tiny, implantable cardiac monitor designed for continuous ECG recording to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope. The United Imaging uCT 780 is a 160-slice CT scanner that provides high-quality, low-dose imaging, particularly for cardiac and detailed anatomical scans, and is also indicated for whole-body imaging and low-dose CT lung cancer screening.

How do the AI capabilities differ between the Reveal LINQ and the uCT 780?

The Reveal LINQ utilizes AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, specifically designed to reduce false alerts for atrial fibrillation and pause. The uCT 780 integrates AI-powered workflows through its uAI Vision 3D camera to enable an efficient, standardized, and personalized scanning experience, enhancing image quality while reducing dose and simplifying examination processes.

What is the patient experience and invasiveness level associated with each device?

The Reveal LINQ is an implantable medical device that requires a minimally invasive, simplified insertion procedure and continuously records ECG for up to three years. The uCT 780 is an on-premise CT scanner, meaning patients undergo a non-invasive imaging scan in a hospital or clinic setting, with features designed for patient comfort and low-dose imaging.

What type of diagnostic information does each tool provide, and how is that data accessed or utilized by clinicians?

The Reveal LINQ provides continuous ECG recordings for up to three years, with data transmitted wirelessly to the CareLinku2122 network via a bedside patient monitor (MyCareLinku2122) and accessible by clinicians through a mobile app (Reveal LINQu2122 Mobile Manager). The uCT 780 generates high-quality, low-dose CT images for detailed anatomical and cardiac diagnostics, which are then interpreted by radiologists and other specialists.

What are the key technological advantages of the Reveal LINQ for cardiac monitoring versus the uCT 780 for cardiac imaging?

The Reveal LINQ's key advantages include its status as the world's smallest insertable cardiac monitor, continuous ECG monitoring for up to three years with AccuRhythmu2122 AI algorithms for reduced false alerts, and MRI Conditional compatibility. The uCT 780 stands out with its 160-slice CT scanner, 0.3s rotation speed, 150ms native temporal resolution, dynamic pitch technology, CardioXphase technology for advanced cardiac diagnostics, and low-dose imaging capabilities with MAC (Metal Artifact Correction).

Beyond cardiology, what other medical specialties would primarily benefit from each tool?

In addition to cardiology, the Reveal LINQ is relevant for neurology due to its application in diagnosing cryptogenic stroke and unexplained syncope. The uCT 780, while strong in cardiology, also serves interventional radiology and general radiology for a broad range of diagnostic imaging needs, including whole-body imaging and lung cancer screening.